Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
152M
-
Number of holders
-
316
-
Total 13F shares, excl. options
-
35.4M
-
Shares change
-
-542K
-
Total reported value, excl. options
-
$5.12B
-
Value change
-
-$123M
-
Put/Call ratio
-
0.29
-
Number of buys
-
136
-
Number of sells
-
-162
-
Price
-
$144.72
Significant Holders of BIO-TECHNE Corp - COMMON STOCK (TECH) as of Q4 2018
373 filings reported holding TECH - BIO-TECHNE Corp - COMMON STOCK as of Q4 2018.
BIO-TECHNE Corp - COMMON STOCK (TECH) has 316 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35.4M shares
of 152M outstanding shares and own 23.22% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.86M shares), Vanguard Group Inc (3.44M shares), BROWN CAPITAL MANAGEMENT LLC (1.7M shares), BAMCO INC /NY/ (1.53M shares), JANUS HENDERSON GROUP PLC (1.44M shares), Neuberger Berman Group LLC (1.43M shares), ATLANTA CAPITAL MANAGEMENT CO L L C (1.35M shares), WELLINGTON MANAGEMENT GROUP LLP (1.29M shares), Mairs & Power INC (1.19M shares), and STATE STREET CORP (905K shares).
This table shows the top 316 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.